Target intelligence / Profile preview

ARHGAP44 and MYOCD antisense RNA 1 (ARHGAP44-AS1)

Target
ARHGAP44-AS1
Molecular classification
Other, long non-coding RNA (lncRNA)
01

Overview

ARHGAP44 and MYOCD antisense RNA 1 (ARHGAP44-AS1) is an RNA gene affiliated with the long non-coding RNA (lncRNA) class and does not code for a protein. This gene appears in genomic databases but lacks extensive functional or disease-role descriptions in current literature as of 2024. As a member of the lncRNA class, it is transcribed from the DNA strand opposite to the protein-coding ARHGAP44 locus. No published evidence currently describes its specific molecular function, biological role, or disease association. Its general class, lncRNA, is known to participate in gene regulation by interacting with chromatin, transcription factors, other RNAs, or the transcriptional machinery, but ARHGAP44-AS1 has not yet been clearly associated with such activity in scientific databases or literature. It is not considered a therapeutic target, nor are there drugs directly targeting it. No drugs are known to interact with it, and it is not reported as a biomarker or associated with any safety concerns due to its lack of known therapeutic or biomarker role. Note that ARHGAP44-AS1 is distinct from ARHGAP44, the protein-coding gene.

02

Biological functions

Unknown/Other
03

Disease associations

Unknown/Other

Beyond the preview

Go deeper on ARHGAP44 and MYOCD antisense RNA 1 (ARHGAP44-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARHGAP44 and MYOCD antisense RNA 1 (ARHGAP44-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call